Multiorganic Dysfunction Syndrome in the Elderly Critically Ill Patient

  • Monica Bonello
  • Zaccaria Ricci
  • Dimitris Petras
  • Nereo Zamperetti
  • Claudior Ronco


Septic Shock Acute Renal Failure Renal Replacement Therapy Acute Lung Injury Acute Respiratory Distress Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eiseman, B., Beart, R., Norton, L. Multiple organ failure. Surg. Gyn. Obstet. 1977; 144:323–326.Google Scholar
  2. 2.
    Fry, D.E., Pearlstein, L., Fulton, R.L., et al, Multiple system organ failure: The role of uncontrolled infection. Arch. Surg. 1980; 115:136–140, 278–283.Google Scholar
  3. 3.
    Bone, R.C., Balk, R.A., Cerra, F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: ACCP/SCCM Consensus Conference Committee. Chest 1992; 101:1644–1655.PubMedCrossRefGoogle Scholar
  4. 4.
    Knaus, W.A., Wagner, D.P., Draper, E.A., et al. The APACHE III prognosis system: Risk prediction of hospital mortality for critically III hospitalized adults. Chest 1991; 100:1619–1636.PubMedCrossRefGoogle Scholar
  5. 5.
    Behrendt, C.E. Acute respiratory failure in the United States: Incidence and 31-day survival. Chest 2000; 118:1100–1105.PubMedCrossRefGoogle Scholar
  6. 6.
    Esteban, A., Anzueto, A., Frutos, F., Alia, I., Brochard, L. Characteristics and outcomes in adult patients receiving mechanical ventilation. A 28-day international study. JAMA 2002; 287:345–355.PubMedCrossRefGoogle Scholar
  7. 7.
    Jakob, S.M., Rothen, H.U. Intensive care 1980–1995: Change in patient characteristics, nursing workload and outcome. Intensive Care Med. 1997; 23:1165–1170.PubMedCrossRefGoogle Scholar
  8. 8.
    McLean, R.F., McIntosh, J.D., Kung, G.Y., Leung, D.M., Byrick, R.J. Outcome of respiratory intensive care for the elderly. Crit. Care Med. 1985; 13:625–629.PubMedCrossRefGoogle Scholar
  9. 9.
    Nicolas, G., Le Gall, J.R., Alperovitch, A., Loirat, P., Villers, D. Influence of patients’ age on survival, level of therapy and length of stay in intensive care units. Intensive Care Med. 1987; 13:9–13.PubMedCrossRefGoogle Scholar
  10. 10.
    Chelluri, L., Pinsky, M.R., Grenvik, A.N. Outcome of intensive care of the “oldest-old” critically ill patients. Crit. Care Med. 1992; 20:757–761.PubMedCrossRefGoogle Scholar
  11. 11.
    Campion, E.W., Mulley, A.G., Goldstein, R.L., et al. Medical intensive care for the elderly. A study of current use, costs, and outcomes. JAMA 1981; 246: 2052–2056.PubMedCrossRefGoogle Scholar
  12. 12.
    Fedullo, A.J., Swinburne, A.J. Relationship of patient age to cost and survival in a medical ICU. Crit. Care Med. 1983; 11:155–159.PubMedCrossRefGoogle Scholar
  13. 13.
    Witek, T.J., Jr., Schachter, E.N., Dean, N.L., Beck, G.J. Mechanically assisted ventilation in a community hospital: Immediate outcome, hospital charges, and follow-up of patients. Arch. Intern. Med. 1985; 145:235–239.PubMedCrossRefGoogle Scholar
  14. 14.
    O’Donnell, A., Bohner, B. Outcome in patients requiring prolonged mechanical ventilation: Three-year experience. Chest 1991; 100:295.CrossRefGoogle Scholar
  15. 15.
    Ely, E.W., Evans, G.W., Haponik, E.F. Mechanical ventilation in a cohort of elderly patients admitted to an intensive care unit. Ann. Intern. Med. 1999; 131:96–104.PubMedGoogle Scholar
  16. 16.
    Seneff, M.G., Wagner, D.P., Wagner, R.P., Zimmerman, J.E., Knaus, W.A. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852–1857.PubMedCrossRefGoogle Scholar
  17. 17.
    Zilberberg, M.D., Epstein, S.K. Acute lung injury in the medical ICU: Comorbid conditions, age, etiology, and hospital outcome. Am. J. Resp. Crit. Care Med. 1998; 157(4 Pt 1):1159– 1164.Google Scholar
  18. 18.
    Ely, E.W., Wheeler, A.P., Thompson, B.T., et al. Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann. Intern. Med. 2002; 136:25–36.PubMedGoogle Scholar
  19. 19.
    Suchyta, M.R., Clemmer, T.P., Elliott, C.G., Orme, J.F., et al. Increased mortality of older patients with acute respiratory distress syndrome. Chest 1997; 111: 1334–1339.PubMedGoogle Scholar
  20. 20.
    Hamel, M.B., Davis, R.B., Teno, J.M., Knaus, W.A., Lynn, J., Harrell, F., Jr., Galanos, A.N., Wu, A.W., Phillips, R.S. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann. Intern. Med. 1999 Nov. 16; 131(10):721–728.PubMedGoogle Scholar
  21. 21.
    Kuhne, C., Ruchholtz, S., Kaiser, G.M., Nast-Kolb, D., Working Group on Multiple Trauma of the German Society of Trauma. Mortality in severely injured elderly trauma patients—When does age become a risk factor? World J. Surg. 2005; 29:1–7.CrossRefGoogle Scholar
  22. 22.
    Maclean, L.D., Mulligan, W.G., Mclean, A.P.H., et al. Patterns of septic shock in man: A detailed study of 56 patients. Ann. Surg. 1967; 166:543–562.PubMedCrossRefGoogle Scholar
  23. 23.
    Bell, R.C., Coalson, J.J., Smith, J.D., et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann. Intern. Med. 1983; 99: 293–298.PubMedGoogle Scholar
  24. 24.
    Tran, D.D., Groeneveld, A.B., van der Meulen, J., et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit. Care Med. 1990; 18:474–479.PubMedCrossRefGoogle Scholar
  25. 25.
    Marshall, J.C., Christou, N.V., Horn, R., et al. The microbiology of multiple organ failure: The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch. Surg. 1988; 123:309–315.PubMedGoogle Scholar
  26. 26.
    D’Amico, G., Pifferi, S., Leonetti, C., et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomized controlled trials. Br. Med. J. 1998; 316:1275–1285.Google Scholar
  27. 27.
    Nathens, A.B., Marshall, J.C. Selective decontamination of the digestive tract (SDD) in surgical patients: A systematic review of the evidence. Arch. Surg. 1999; 134:170–176.PubMedCrossRefGoogle Scholar
  28. 28.
    Norton, L.W. Does drainage of intraabdominal pus reverse multiple organ failure? Am. J. Surg. 1985; 149:347–350.PubMedCrossRefGoogle Scholar
  29. 29.
    Nathens, A.B., Rotstein, O.D., Marshall, J.C. Tertiary peritonitis: Clinical features of a complex nosocomial infection. World J. Surg. 1998; 22:158–163.PubMedCrossRefGoogle Scholar
  30. 30.
    Wunderink, R.G. Attributable mortality of ventilator-associated pneumonia. Sepsis 1997; 1:211–221.CrossRefGoogle Scholar
  31. 31.
    Markowicz, P., Wolff, M., Djedaini, K., et al. Multicenter prospective study of ventilatorassociated pneumonia during acute respiratory distress syndrome: The ARDS Study Group. Am. J. Resp. Crit. Care Med. 2000; 161:1942–1948.PubMedGoogle Scholar
  32. 32.
    Marshall, J.C., Sweeney, D. Microbial infection and the septic response in critical surgical illness: Sepsis, not infection, determines outcome. Arch. Surg. 1990; 125:17–23.PubMedGoogle Scholar
  33. 33.
    Rivers, E., and The Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 2001; 345:1368–1377.PubMedCrossRefGoogle Scholar
  34. 34.
    Bernard, G.R., Hartman, D.L., Helterbrand, J.D., et al. Recombinant human activated protein C (rhAPC) produces a trend toward improvement in morbidity and 28-day survival in patients with severe sepsis. Crit. Care Med. 1999; 27: A33–118.CrossRefGoogle Scholar
  35. 35.
    Bernard, G.R., Vincent, J.-L., Laterre, P.-F., et al. Efficacy and safety of recombinant activated protein C for severe sepsis. N. Engl. J. Med. 2001; 344: 699–709.PubMedCrossRefGoogle Scholar
  36. 36.
    Seely, A.J.E., Christou, N.V. Multiple organ dysfunction syndrome: Exploring the paradigm of complex nonlinear systems. Crit. Care Med. 2000; 28: 2193–2200.PubMedCrossRefGoogle Scholar
  37. 37.
    Marshall, J.C. Complexity, chaos, and incomprehensibility: Parsing the biology of critical illness. Crit. Care Med. 2000; 28:2646–2648.PubMedCrossRefGoogle Scholar
  38. 38.
    Nathens, A.B., Marshall, J.C. Selective decontamination of the digestive tract in surgical patients: A systematic review of the evidence. Arch. Surg. 1999; 134:170–176.PubMedCrossRefGoogle Scholar
  39. 39.
    Marshall, J.C. Clinical trials of mediator-directed therapy in sepsis: What have we learned? Intensive Care Med. 2000; 26:S75–S83.PubMedCrossRefGoogle Scholar
  40. 40.
    Singer, M., De Santis, V., Vitale, D., Jeffcoate, W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545–548.PubMedCrossRefGoogle Scholar
  41. 41.
    Albright, R.C. Acute renal failure: A practical update. Mayo Clin. Proc. 2001; 76:67–74.PubMedCrossRefGoogle Scholar
  42. 42.
    Hou, S.H., Bushinsky, D.A., Wish, J.B., et al, Hospital acquired renal insufficiency: A prospective study. Am. J. Med. 1983; 74:243–248.PubMedCrossRefGoogle Scholar
  43. 43.
    Nash, K., Hafeez, A., Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 2002; 39:930–936.PubMedCrossRefGoogle Scholar
  44. 44.
    Behrend, T., Miller, S.B. Acute renal failure in the cardiac care unit: Etiologies, outcomes, and prognostic factors. Kidney Int. 1999; 56:238–243.PubMedCrossRefGoogle Scholar
  45. 45.
    Bennett, W.M. Posttransplant acute renal failure. Ren. Fail. 1997; 19:225–226.PubMedGoogle Scholar
  46. 46.
    DuBose, T.D., Jr., Warnock, D.G., Mehta, R.L., Bonventre, J.V., Hammerman, M.R., Molitoris, B.A., Paller, M.S., Siegel, N.J., Scherbenske, J., Striker, G.E. Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. Am. J. Kidney Dis. 1997; 29:793–799.PubMedGoogle Scholar
  47. 47.
    Clermont, G., Acker, C.G., Angus, D.C., Sirio, C.A., Pinsky, M.R., Johnson, J.P. Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int. 2002; 62:986–996.PubMedCrossRefGoogle Scholar
  48. 48.
    Metcalfe, W., Simpson, M., Khan, I.H., Prescott, G.J., Simpson, K., Smith, W.C., MacLeod, A.M. Acute renal failure requiring renal replacement therapy: Incidence and outcome. Quar. J. Med. 2002; 95:579–583.Google Scholar
  49. 49.
    Liano, F., Junco, E., Pascual, J., Madero, R., Verde, E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. 1998; 66:S16–S24.Google Scholar
  50. 50.
    Pruchnicki, M.C., Dasta, J.F. Acute renal failure in hospitalized patients: Part I. Ann. Pharmacother. 2002; 36:1261–1267.PubMedCrossRefGoogle Scholar
  51. 51.
    De Mendonca, A., Vincent, J.-L., Suter, P.M., et al. Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000; 26:915–921.PubMedCrossRefGoogle Scholar
  52. 52.
    Chertow, G.M., Levy, E.M., Hammermeister, K.E., Grover, F., Daley, J. Independent association between acute renal failure and mortality following cardiac surgery. Am. J. Med. 1998; 104:343–348.PubMedCrossRefGoogle Scholar
  53. 53.
    Shusterman, N., Strom, B.L., Murray, T.G., Morrison, G., West, S.L., Maislin, G. Risk factors and outcome of hospital-acquired acute renal failure. Am. J. Med. 1987; 83:65–71.PubMedCrossRefGoogle Scholar
  54. 54.
    Silvester, W., Bellomo, R., Cole, L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit. Care Med. 2001; 29:1910–1915.PubMedCrossRefGoogle Scholar
  55. 55.
    Vincent, J.L. Incidence of acute renal failure in the intensive care unit. Contrib. Nephrol. 2001; 132:1–6.PubMedGoogle Scholar
  56. 56.
    Liano, F., Pascual, J. Outcomes in acute renal failure. Semin. Nephrol. 1998; 18:541–550.PubMedGoogle Scholar
  57. 57.
    Abernethy, V.E., Lieberthal, W. Acute renal failure in the critically ill patient. Crit. Care Clin. 2002; 18:203–222.PubMedCrossRefGoogle Scholar
  58. 58.
    Bates, D.W., Su, L., Yu, D.T., Chertow, G.M., Seger, D.L., Gomes, D.R., Platt, R. Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int. 2001; 60:1452–1459.PubMedCrossRefGoogle Scholar
  59. 59.
    Brivet, F.G., Kleinknecht, D.J., Loirat, P., Landais, P.J. Acute renal failure in intensive care units: Causes, outcome, and prognostic factors of hospital mortality—A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit. Care Med. 1996; 24: 192–198.PubMedCrossRefGoogle Scholar
  60. 60.
    Butkus, D.E. Persistent high mortality in acute renal failure. Arch. Intern. Med. 1983; 143:209–212.PubMedCrossRefGoogle Scholar
  61. 61.
    Chertow, G.M., Christiansen, C.L., Cleary, P.D., Munro, C., Lazarus, J.M. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch. Intern. Med. 1995; 155:1505–1511.PubMedCrossRefGoogle Scholar
  62. 62.
    Menashe, P.I., Ross, S.A., Gottlieb, J.E. Acquired renal insufficiency in critically ill patient. Crit. Care Med. 1988; 16:1106–1109.PubMedCrossRefGoogle Scholar
  63. 63.
    Mangano, C.M., Diamondstone, L.S., Ramsay, J.G., Aggarral, A., Herskowitz, A., Mangano, D.T. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcome, and hospital resource utilization. Ann. Intern. Med. 1998; 128:194–203.PubMedGoogle Scholar
  64. 64.
    Vivino, G., Antonelli, M., Moro, M.L., Cottini, F., Conti, G., Bufi, M., et al. Risk factors for acute renal failure in trauma patients. Intensive Care Med. 1998; 24:808–814.PubMedCrossRefGoogle Scholar
  65. 65.
    Wiecek, A., Zeier, M., Ritz, E. Role of infection in the genesis of acute renal failure. Nephrol. Dial. Transplant 1994; 9(Suppl 4):40–44.PubMedGoogle Scholar
  66. 66.
    Ward, M.M. Factors predictive of acute renal failure in rhabdomyolysis. Arch. Intern. Med. 1988; 148:1553–1557.PubMedCrossRefGoogle Scholar
  67. 67.
    Myers, B.D., Moran, S.M. Hemodynamically mediated acute renal failure. N. Engl. J. Med. 1986; 314:97–100.PubMedCrossRefGoogle Scholar
  68. 68.
    Lieberthal, W., Nigam, S.K. Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am. J. Physiol. Ren. Physiol. 2000; 278:F1–F12.Google Scholar
  69. 69.
    Rosen, S., Heyman, S.N. Difficulties in understanding human “acute tubular necrosis”: Limited data and flawed animal models. Kidney Int. 2001; 60: 220–1224.CrossRefGoogle Scholar
  70. 70.
    Ueda, N., Kaushal, G.P., Shah, S.V. Apoptotic mechanisms in acute renal failure. Am. J. Med. 2000; 108:403–415.PubMedCrossRefGoogle Scholar
  71. 71.
    Heyman, S.N., Lieberthal, W., Rogiers, P., Bonventre, J.V. Animal models of acute tubular necrosis. Curr. Opin. Crit. Care 2002; 8:526–534.PubMedCrossRefGoogle Scholar
  72. 72.
    Sutton, T.A., Fisher, C.J., Molitoris, B.A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002; 62: 1539–1549.PubMedCrossRefGoogle Scholar
  73. 73.
    Wang, S., Hirschberg, R. Role of growth factors in acute renal failure. Nephrol. Dial. Transplant 1997; 12:1560–1563.PubMedCrossRefGoogle Scholar
  74. 74.
    Meyer, M., Richter, R., Forssmann, W.G. Urodilatin, a natriuretic peptide with clinical implications. Eur. J. Med. Res. 1998; 3:103–110.PubMedGoogle Scholar
  75. 75.
    Lieberthal, W. Biology of ischemic and toxic renal tubular cell injury: Role of nitric oxide and the inflammatory response. Curr. Opin. Nephrol. Hypertens. 1998; 7:289–295.PubMedGoogle Scholar
  76. 76.
    Venkataram, R., Kellum, J.A. The role of diuretic agents in the management of acute renal failure. Contrib. Nephrol. 2001; 132:158–170.PubMedGoogle Scholar
  77. 77.
    Solomon, R., Werner, C., Mann, D., D’Elia, J., Silva, P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N. Engl. J. Med. 1994; 331:1416–1420.PubMedCrossRefGoogle Scholar
  78. 78.
    Kellum, J.A., Decker, J.M. Use of dopamine in acute renal failure: A meta-analysis. Crit. Care Med. 2001; 29:1526–1531.PubMedCrossRefGoogle Scholar
  79. 79.
    Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: A placebo controlled randomized trial. Lancet 2000; 356:2139–2143.Google Scholar
  80. 80.
    Allgren, R.L., Marbury, T.C., Rahman, S.N., Weisberg, L.S., Fenves, A.Z., Lafayette, R.A., Sweet, R.M., Genter, F.C., Kurnik, B.R., Conger, J.D., Sayegh, M.H. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N. Engl. J. Med. 1997; 336:828–834.PubMedCrossRefGoogle Scholar
  81. 81.
    Lewis, J., Salem, M.M., Chertow, G.M., Weisberg, L.S., McGrew, F., Marbury, T.C., Allgren, R.L. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am. J. Kidney Dis. 2000; 36: 767–774.PubMedGoogle Scholar
  82. 82.
    Hirschberg, R., Kopple, J., Lipsett, P., Benjamin, E., Minei, J., Albertson, T., Munger, M., Metzler, M., Zaloga, G., Murray, M., Lowry, S., Conger, J., McKeown, W., O’Shea, M., Baughman, R., Wood, K., Haupt, M., Kaiser, R., Simms, H., Warnock, D., Summer, W., Hintz, R., Myers, B., Haenftling, K., Capra, W., et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 1999; 55: 2423–2432.PubMedCrossRefGoogle Scholar
  83. 83.
    Wang, A., Holcslaw, T., Bashore, T.M., Freed, M.I., Miller, D., Rudnick, M.R., Szerlip, H., Thames, M.D., Davidson, C.J., Shusterman, N., Schwab, S.J. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int. 2000; 57:1675–1680.PubMedCrossRefGoogle Scholar
  84. 84.
    Marshall, J.C. Inflammation, coagulopathy, and pathogenesis of multiple organ dysfunction syndrome. Crit. Care Med. 2001; 29(S9):S99–S106.PubMedCrossRefGoogle Scholar
  85. 85.
    Jorres, A. Acute renal failure. Extracorporeal treatment strategies. Minerva Med. 2002; 93:329–334.PubMedGoogle Scholar
  86. 86.
    Mehta, R., Clark, W.C., Schetz, M. Techniques for assessing and achieving fluid balance in acute renal failure. Curr. Opin. Crit. Care 2002; 8:535–543.PubMedCrossRefGoogle Scholar
  87. 87.
    Martin, C., Papazian, L., Perrin, G., Saux, P., Gouin, F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826–1831.PubMedCrossRefGoogle Scholar
  88. 88.
    Bellomo, R., DiGiantomasso, D. Noradrenaline and the kidney: Friends or foes? Crit. Care 2001; 5:294–298.PubMedCrossRefGoogle Scholar
  89. 89.
    Ravikant, T., Lucas, C.E. Renal blood flow distribution in septic hyperdynamic pigs. J. Surg. Res. 1977; 22:294–298.PubMedCrossRefGoogle Scholar
  90. 90.
    Brenner, M., Schaer, G.L., Mallory, D.L., Suffredini, A.F., Parrillo, J.E. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990; 98:170–179.PubMedCrossRefGoogle Scholar
  91. 91.
    DiGiantomasso, D., Morimatsu, H., May, C.N., Bellomo, R. Intra-renal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit. Care Med. 2003; 31:2509–2513.CrossRefGoogle Scholar
  92. 92.
    Knotek, M., Rogachev, B., Wang, W., et al. Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int. 2001; 59:2243–2247.PubMedGoogle Scholar
  93. 93.
    Liberthal, W., Levine, J.S. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 1996; 271:F477–F488.Google Scholar
  94. 94.
    Jo, S.K., Cha, D.R., Cho, W.Y., et al. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 2002; 91:406–415.PubMedCrossRefGoogle Scholar
  95. 95.
    Rodriguez-Wilhelmi, P., Montes, R., Matsukawa, A., et al. Tumour necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock. J. Lab. Clin. Med. 2003; 141:257–264.PubMedCrossRefGoogle Scholar
  96. 96.
    Bernard, G.R., Vincent, J.-L., Laterre, R.-F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 2001; 344:699–709.PubMedCrossRefGoogle Scholar
  97. 97.
    Joyce, D.E., Gelbert, L., Ciaccia, A., et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J. Biol. Chem. 2001; 276:11199–11203.PubMedCrossRefGoogle Scholar
  98. 98.
    Cheng, T., Liu, D., Griffin, J.H., et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat. Med. 2003; 9:338–342.PubMedCrossRefGoogle Scholar
  99. 99.
    Fauvel, H., Marchetti, P., Chopin, C., Formastecher, P., Neviere, R. Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2001; 280: H1608–H1614.PubMedGoogle Scholar
  100. 100.
    Neviere, R., Fauvel, H., Chopin, C., Formstecher, P., Marchetti, P. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am. J. Resp. Crit. Care Med. 2001; 163:218–225.PubMedGoogle Scholar
  101. 101.
    Cauwels, A., Janssen, B., Waeytens, A., Cuvelier, C., Brouckaert, P. Caspase inhibition causes hyperacute tumous necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 2003; 4:387–393.PubMedCrossRefGoogle Scholar
  102. 102.
    Van den Berghe, G., Wouters, P., Weekers, F., et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 2001; 345:1359–1367.PubMedCrossRefGoogle Scholar
  103. 103.
    Hansen, T.K., Thiel, S., Wouters, P.J., et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. Endocr. Metab. 2003; 88:1082–1088.PubMedCrossRefGoogle Scholar
  104. 104.
    Augustin, R., Pocar, P., Wrenzycki, C., Niemann, H., Fischer, B. Mitogenic and anti-apoptotic activity of insulin on bovine embryos produced in vitro. Reproduction 2003; 126:91–99.Google Scholar
  105. 105.
    Allen, D.A., Harwood, S., Varagunam, M., Raftery, M.J., Yaqoob, M.M. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J. 2003; 17:908–910.PubMedGoogle Scholar
  106. 106.
    The ARDS Network. Ventilation with low tidal volumes as compared to traditional tidal volumes for acute lung injury and acute respiratory distress syndrome. N. Engl. J. Med. 2000; 342:1301–1308.Google Scholar
  107. 107.
    Imai, Y., Parodo, J., Kajikawa, O., et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003; 289:2104–2112.PubMedCrossRefGoogle Scholar
  108. 108.
    Birck, R., Krzossok, S., Markowetz, F., et al. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003; 362:598–603.PubMedCrossRefGoogle Scholar
  109. 109.
    Ozdulger, A., Cinel, I., Koksel, O., et al. The protective effect of N-acetylcysteine on apoptotic lung injury in a cecal ligation and puncture-induced sepsis model. Shock 2003; 19:366–372.PubMedCrossRefGoogle Scholar
  110. 110.
    Bellomo, R., Ronco, C. Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int. 1998; 53(Suppl 66):S106–109.Google Scholar
  111. 111.
    Ronco, C., Bellomo, R., Brendolan, A., Pinna, V., La Greca, G. Brain density changes during renal replacement therapy in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J. Nephrol. 1999; 12:173–178.PubMedGoogle Scholar
  112. 112.
    Guisado, R., Arieff, A.I. Neurologic manifestations of diabetic comas: Correlation with biochemical alterations in the brain. Metabolism 1975; 24:665–679.PubMedCrossRefGoogle Scholar
  113. 113.
    Sussman, N.L., Kelly, J.H. Extracorporeal liver support and the kidney. In Critical Care Nephrology, C. Ronco and R. Bellomo, eds. Dordrecht: Kluwer Academic Publishers. 1998; pp. 959–967.Google Scholar
  114. 114.
    Silvester, W. Mediator removal with CRRT: Complement and cytokines. Am. J. Kidney Dis. 1997; 30(Suppl 4):S38–43.PubMedGoogle Scholar
  115. 115.
    Hoffmann, J.N., Hartl, W.H., Deppisch, R., et al. Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int. 1995; 48:1563–1570.PubMedCrossRefGoogle Scholar
  116. 116.
    Gasche, Y., Pascual, M., Suter, P.M., et al. Complement depletion during haemofiltration with polyacilonitrile membranes. Nephrol. Dial. Transplant 1996; 11:117–119.PubMedGoogle Scholar
  117. 117.
    Bellomo, R., Tipping, P., Boyce, N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit. Care Med. 1993; 21:522–526.PubMedCrossRefGoogle Scholar
  118. 118.
    Ronco, C., Tetta, C., Lupi, A., et al. Removal of platelet-activating actor in experimental continuous arteriovenous hemofiltration. Crit. Care Med. 1995; 23:99–107.PubMedCrossRefGoogle Scholar
  119. 119.
    Cole, L., Bellomo, R., Journois, D., et al. Aphase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit. Care Med. 2002; 30:100–106.PubMedCrossRefGoogle Scholar
  120. 120.
    De Vriese, A.S., Vanholder, R.C., Pascual, M., et al. Can inflammatory cytokines be removed efficiently by continous renal replacement therapies? Intensive Care Med. 1999; 25:903–910.PubMedCrossRefGoogle Scholar
  121. 121.
    Ronco, C., Bellomo, R., Homel, P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26–30.PubMedCrossRefGoogle Scholar
  122. 122.
    Honore, P.M., Jamez, J., Wauthier, M., et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit. Care Med. 2000; 28:3581–3587.PubMedCrossRefGoogle Scholar
  123. 123.
    Tetta, C., Cavaillon, J.M., Schulze, M., et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol. Dial. Transplant 1998; 13:1458–1464.PubMedCrossRefGoogle Scholar
  124. 124.
    Ronco, C., Brendolan, A., Lonnemann, G., et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit. Care Med. 2002; 30: 1250–1255.PubMedCrossRefGoogle Scholar
  125. 125.
    Lee, M., Ganzini, L. Depression in the elderly: Effect on patient attitudes toward life-sustaining therapy. J. Am. Geriatr, Soc. 1992; 40(10):983–988.PubMedGoogle Scholar
  126. 126.
    Chelluri, L., Mendelsohn, A.B., Belle, S.H., Rotondi, A.J., Angus, D.C., Donahoe, M.P., Sirio, C.A., Schulz, R., Pinsky, M.R. Hospital costs in patients receiving prolonged mechanical ventilation: Does age have an impact? Crit. Care Med. 2003; 31(6):1746–1751.PubMedCrossRefGoogle Scholar
  127. 127.
    Hamel, M.B., Lynn, J., Teno, J., Covinsky, K.E., Wu, A.W., Galanos, A., Desbiens, N.A., Phillips, R.S. Age-related differences in care preferences, treatment decisions, and clinical outcomes of seriously ill hospitalized adults: Lessons from SUPPORT. J. Am. Geriatr. Soc. 2000; 48(5 Suppl):S176–182.PubMedGoogle Scholar
  128. 128.
    Hamel, M.B., Phillips, R.S., Davis, R.B., Teno, J., Desbiens, N., Lynn, J., Tsevat, J. Are aggressive treatment strategies less cost-effective for older patients? The case of ventilator support and aggressive care for patients with acute respiratory failure. J. Am. Geriatr. Soc. 2001; 49(4):382–390.PubMedCrossRefGoogle Scholar
  129. 129.
    Montuclard, L., Garrouste-Orgeas, M., Timsit, J.F., De Jonghe, B., Carlet, J. Outcome, functional autonomy, and quality of life of elderly patients with a long-term intensive care unit stay. Crit. Care Med. 2000; 28(10):3389–3395.PubMedCrossRefGoogle Scholar
  130. 130.
    Udekwu, P., Gurkin, B., Oller, D., Lapio, L., Bourbina, J. Quality of life and functional level in elderly patients surviving surgical intensive care. J. Am. Coll. Surg. 2001 Sept; 193(3):245–249.PubMedCrossRefGoogle Scholar
  131. 131.
    Tsevat, J., Dawson, N.V., Wu, A.W., Lynn, J., Soukup, J.R., Cook, E.F., Vidaillet, H., Phillips, R.S. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA 1998; 279(5):371–375.PubMedCrossRefGoogle Scholar
  132. 132.
    Lloyd, C.B., Nietert, P.J., Silvestri, G.A. Intensive care decision making in the seriously ill and elderly. Crit. Care Med. 2004 Mar; 32(3):649–654.Google Scholar
  133. 133.
    Somogyi-Zalud, E., Zhong, Z., Hamel, M.B., Lynn, J. The use of life-sustaining treatments in hospitalized persons aged 80 and older. J. Am. Geriatr. Soc. 2002; 50(5):930–934.PubMedCrossRefGoogle Scholar
  134. 134.
    The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995; 274: 1591–1598.Google Scholar
  135. 135.
    Hammes, B.J., Rooney, B.L. Death and end-of-life planning in one Midwestern community. Arch. Intern. Med. 1990; 158:383–390.CrossRefGoogle Scholar
  136. 136.
    Prendergast, T.J. Advance care planning: Pitfalls, progress, promise. Crit. Care Med. 2001; 29(2-Suppl):N34–N39.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Monica Bonello
  • Zaccaria Ricci
  • Dimitris Petras
  • Nereo Zamperetti
  • Claudior Ronco

There are no affiliations available

Personalised recommendations